Tag Archives: JNJ

The Dow Propped Up by Johnson & Johnson, Pfizer Thursday

March 8, 2018: Markets opened higher Thursday but all three major indexes visit the downside today before settling above the break-even line. Trade-war fears have eased somewhat, and reports the Canada and Mexico would not be included in the initial round. The report on new claims for unemployment benefits was also encouraging.

WTI crude oil for April delivery settled at $60.12 a barrel,....More>>>

Starbucks For The Long Term

In the early 1970s the “Nifty 50” were all the rage – growth stocks like International Business Machines (NYSE:IBM), Xerox (NYSE:XRX) General Electric (NYSE:GE), Coca-Cola (NYSE:KO), Procter & Gamble (NYSE:PG), Sears Roebuck (NASDAQ:SHLD), Johnson & Johnson (NYSE:JNJ), McDonald’s (NYSE:MCD), Polaroid and Eastman Kodak (NYSE:KODK), to name a few. In 1973-1974....More>>>

1 Thing About Pfizer, Inc. Stock That You Might Be Overlooking”

There are several things about Pfizer (NYSE:PFE) stock for investors to like. Its dividend is a biggie. The potential for growth from products such as Ibrance and Xeljanz definitely makes the list. So does growth-driving newer drugs like Eucrisa.

But what about Pfizer’s essential health business segment? This business might seem boring compared to the company’s innovative....More>>>

Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand”

When it comes to safe stocks, there may be none safer than healthcare conglomerate Johnson & Johnson (NYSE:JNJ). Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors. It has a 54-year streak of increasing its dividend payout, which should almost certainly become 55 years come April, and it’s one of two remaining publicly....More>>>